# Final Residual Risk and Business Acceptance Record

**Record:** Final Residual Risk and Business Acceptance Record  
**Evidence focus:** `GOLIVE-011`, with trace to security, deployment, observability, DR, performance, integration, and pilot risks  
**Status:** Template/evidence-control record

## 1. Purpose

This record consolidates residual risk before production-wide go-live. It must be completed by named humans and linked to the final go-live authorization record.

## 2. Residual Risk Register

| Risk ID | Source package | Risk description | Severity | Mitigation / condition | Owner | Target closure | Business acceptance |
|---|---|---|---|---|---|---|---|
| RISK-GOLIVE-001 | P5-1 / Security | `<redacted-risk-summary>` | Pending | `<mitigation>` | Security Owner | `<date>` | Pending |
| RISK-GOLIVE-002 | P5-2 / Deployment | `<redacted-risk-summary>` | Pending | `<mitigation>` | DevOps | `<date>` | Pending |
| RISK-GOLIVE-003 | P5-3 / Observability | `<redacted-risk-summary>` | Pending | `<mitigation>` | Operations | `<date>` | Pending |
| RISK-GOLIVE-004 | P5-4 / DR | `<redacted-risk-summary>` | Pending | `<mitigation>` | Operations / DevOps | `<date>` | Pending |
| RISK-GOLIVE-005 | P5-5 / Performance lifecycle | `<redacted-risk-summary>` | Pending | `<mitigation>` | Lead Engineer | `<date>` | Pending |
| RISK-GOLIVE-006 | P5-6 / Integration | `<redacted-risk-summary>` | Pending | `<mitigation>` | Integration Owner | `<date>` | Pending |
| RISK-GOLIVE-007 | Pilot | `<redacted-risk-summary>` | Pending | `<mitigation>` | Product Owner | `<date>` | Pending |

## 3. Business Acceptance Criteria

Final business acceptance requires:

- all blocker and critical risks closed or explicitly no-go;
- high risks either closed or accepted by named humans with target closure dates;
- pilot blockers and critical defects closed or no-go;
- security and go-live residual risk accepted by named humans only;
- rollback, hypercare, monitoring, and support paths active;
- legal/commercial exclusions and known limitations clearly stated.

AI/n8n/service actors cannot accept final residual risks, cannot approve business acceptance, cannot waive missing evidence, and cannot sign final production authorization.

## 4. Exclusion Reminder

The following remain controlled exclusions unless separately implemented, validated, and approved:

- full API 579;
- full API 581;
- copied API/API-ASME formulas;
- 3D processing;
- direct external CMMS production cutover without approved integration readiness and fallback;
- any n8n direct PostgreSQL write path.

## 5. Human Acceptance

| Role | Name | Acceptance decision | Conditions | Date | Approval reference |
|---|---|---|---|---|---|
| Product Owner / Business Sponsor | `<name>` | Pending | `<conditions>` | `<date>` | `<reference>` |
| Security Owner | `<name>` | Pending | `<conditions>` | `<date>` | `<reference>` |
| Release Manager | `<name>` | Pending | `<conditions>` | `<date>` | `<reference>` |
| Operations / Hypercare Owner | `<name>` | Pending | `<conditions>` | `<date>` | `<reference>` |


## 6. Exact Human-Only Risk Markers

AI/n8n/service actors cannot accept final residual risks.
AI/n8n/service actors cannot approve business acceptance.
AI/n8n/service actors cannot sign final production authorization.
